Curon Biopharmaceutical
Latest round
- Series A
Last raised
- Jul 2018
Total raised
- $150M
Investors
- 3
About Curon Biopharmaceutical
Based in China, Curon Biopharmaceutical operates as a developer of novel cancer immuno-therapeutic agents.
Who invested in Curon Biopharmaceutical
3 investors across 1 round
See all investors in Curon Biopharmaceutical
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jul 30, 2018
Amount
$150M
Investors
Questions about Curon Biopharmaceutical
Who invested in Curon Biopharmaceutical?
Curon Biopharmaceutical has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Curon Biopharmaceutical raised?
Curon Biopharmaceutical has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Curon Biopharmaceutical last raise money?
Curon Biopharmaceutical's most recent round on record is a Series A, in Jul 2018.
What does Curon Biopharmaceutical do?
Based in China, Curon Biopharmaceutical operates as a developer of novel cancer immuno-therapeutic agents.
Where is Curon Biopharmaceutical headquartered?
Curon Biopharmaceutical is headquartered in Shanghai, China.
Which VCs invest in companies like Curon Biopharmaceutical?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Curon Biopharmaceutical's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Curon Biopharmaceutical? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.